Inducible Nitric Oxide Synthase Inhibition Reverses Pulmonary Arterial Dysfunction in Lung Transplantation.

Jing-xiang Wu,Hong-wei Zhu,Xu Chen,Jiong-lin Wei,Xiao-feng Zhang,Mei-ying Xu
DOI: https://doi.org/10.1007/s00011-014-0733-5
IF: 6.986
2014-01-01
Inflammation Research
Abstract:Ischemia–reperfusion injury (IRI) after lung transplantation remains a significant cause of morbidity and mortality. Lung IRI induces nitric oxide synthesis (iNOS) and reactive nitrogen species, decreasing nitric oxide bioavailability. We hypothesized that ischemia-induced iNOS intensifies with reperfusion and contributes to IRI-induced pulmonary arterial regulatory dysfunction, which may lead to early graft failure and cause pulmonary edema. The aim of this study was to determine whether ischemia–reperfusion alters inducible and endothelial nitric oxide synthase expression, potentially affecting pulmonary perfusion. We further evaluated the role of iNOS in post-transplantation pulmonary arterial disorder.
What problem does this paper attempt to address?